Which has the lower trailing P/E, CDNA or VCYT?

CDNA has the lower trailing P/E: CDNA trades at 31.16 and VCYT at 31.55. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CDNA or VCYT?

Over the past five years, VCYT grew revenue faster — CDNA at a 12.56% CAGR versus VCYT at 28.98%.

Is CDNA or VCYT more profitable?

CDNA runs the higher net margin — CDNA at 24.23% versus VCYT at 20.37%.

How have CDNA and VCYT total returns compared?

Over the past 10 years, CDNA delivered 34.41% and VCYT delivered 19.91% annualized total return. Past performance doesn't predict future results.

CareDx, Inc (CDNA) vs Veracyte, Inc. (VCYT)

A side-by-side comparison of CareDx, Inc and Veracyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CDNA

CareDx, Inc

$3.34B

$64.53HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

VCYT

Veracyte, Inc.

$3.52B

$44.18HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

Total return — CDNA vs VCYT

growth of $100 · dividends reinvested · last 10y

CDNA +1824.2% (+34.4%/yr)VCYT +521.5% (+20.0%/yr)CDNA compounded faster over this window

CDNA VCYT

CDNA vs VCYT: by the numbers

•VCYT is the larger company ($3.52B vs $3.34B market cap).
•CDNA trades at the lower trailing earnings multiple (31.16 vs 31.55 P/E), one valuation lens rather than an overall verdict.
•CDNA converts more revenue to profit (24.23% vs 20.37% net margin).
•VCYT grew revenue faster over the past five years (28.98% vs 12.56% CAGR).

Metrics side by side

Valuation

Metric	CDNA	VCYT
P/E ratio	31.16	31.55
Forward P/E	53.88	23.08
P/S ratio	7.29	6.27
P/B ratio	7.84	2.54
EV / EBITDA	191.80	28.02
FCF yield	2.55%	4.69%

Profitability

Metric	CDNA	VCYT
Gross margin	70.58%	72.09%
Operating margin	-0.92%	17.03%
Net margin	24.23%	20.37%
ROE	26.08%	8.25%
ROIC	-0.93%	6.72%

Growth (annualized)

Metric	CDNA	VCYT
Revenue CAGR (5Y)	12.56%	28.98%
Total return CAGR (5Y)	1.33%	1.45%

Frequently asked

Which has the lower trailing P/E, CDNA or VCYT?: CDNA has the lower trailing P/E: CDNA trades at 31.16 and VCYT at 31.55. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CDNA or VCYT?: Over the past five years, VCYT grew revenue faster — CDNA at a 12.56% CAGR versus VCYT at 28.98%.
Is CDNA or VCYT more profitable?: CDNA runs the higher net margin — CDNA at 24.23% versus VCYT at 20.37%.
How have CDNA and VCYT total returns compared?: Over the past 10 years, CDNA delivered 34.41% and VCYT delivered 19.91% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CDNA analysis Full VCYT analysis Interactive comparison tool

Dig into the metrics

CareDx P/E ratio Veracyte P/E ratio CareDx ROE Veracyte ROE CareDx operating margin Veracyte operating margin CareDx revenue growth Veracyte revenue growth CareDx free cash flow Veracyte free cash flow

CareDx & Veracyte appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.